A detailed history of Aviso Financial Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Aviso Financial Inc. holds 105 shares of LLY stock, worth $87,311. This represents 0.01% of its overall portfolio holdings.

Number of Shares
105
Holding current value
$87,311
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $76,111 - $95,449
105 New
105 $95.1 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $790B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Aviso Financial Inc. Portfolio

Follow Aviso Financial Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviso Financial Inc., based on Form 13F filings with the SEC.

News

Stay updated on Aviso Financial Inc. with notifications on news.